Hadassah Announces 97 Percent Success Rate with New Hepatitis C Treatment

Monday, Aug 24 2015

The treatment is a combination of Viekarax and Exviera, and was developed by AbbVie, it has now been approved by the Federal Drug Administration and Israel’s Ministry of Health.

“Hepatitis C used to be a death sentence,” reports Prof. Rifaat Safadi, head of the Liver Unit at the Hadassah Medical Organization. He explains, however, that Hadassah has achieved 97 percent success in treating the disease using a new combination of medicines clinically tested at Hadassah and other leading medical centers worldwide.

One of the 100 patients to receive the treatment at Hadassah was Ava Avidar, a mother of three who had undergone a liver transplant. Tragically, she had previously contracted Hepatitis C and the virus which remained in her body attacked her new liver, too. The medicine defeated the virus, however, and she is now doing very well, according to Prof. Safadi. As Mrs. Avidar relates, “It’s nothing short of getting my life back as a gift.”

Now six months post treatment, Mrs. Avidar is free of the virus, has moved to a new home, and returned to her work as a sculptress.

Recalling the journey to health for Mrs. Avidar, Prof. Safadi says: “We began a race against the clock and had to come up with an urgent solution before the new liver failed.” While the new treatment had not yet been approved by Israel’s Ministry of Health, Prof. Safadi believed the medication would save her. Still, his patient could not afford the $100,000 it would cost for the three months of treatment. Fortunately, Mrs. Avidar found the strength to fight her private health insurance company and won her battle, Prof. Safadi relates. 

The treatment, a combination of Viekarax and Exviera, developed by AbbVie, has now been approved by the Federal Drug Administration and Israel’s Ministry of Health, thanks to the success achieved at Hadassah and the other international clinical trials. Prof. Sifadi was also instrumental in getting the new treatment incorporated into Israel’s 2015 health insurance basket, so patients can now receive coverage for this life-saving treatment.


From: nancy Russo on March 7, 2016
If Gilead is an Isralie drug company how come you didn't use Harvoni?
From: Mary on September 5, 2015
With the medicines for Hep C, do you have anything working for pancreatic cancer?
From: Janet on August 27, 2015
Can you help????
From: Sharon on August 26, 2015
This is Wonderful news! I was a Hep C advocate and patient on the old regimen in 1999 and started a non profit HCV support group. The old meds were very hard on the body with many side effects & after 1 year on this I have been viral free for 15 yrs! Thank You Hadassah Hospital for your continued research to improve the cure rate for this horrific liver disease that millions have and may not even know. Keep up All your Wonderful Work!
First Name
Enter this word:

Related Stories


Wednesday, Oct 19 2016

Caryn Andrews: Hadassah Nurse Practitioner on a Mission

Nurse Practitioner Caryn Scheinberg Andrews, who immigrated to Israel from Baltimore, Maryland in 2011 and is a lecturer in the Hadassah-Hebrew University Henrietta Szold School of Nursing, is on a personal mission: to fortify Israel's health delivery capacity by helping to create a cadre of advanced practice nurses.


Wednesday, Oct 5 2016

Russian Children Travel to Hadassah to be Treated For a Rare Disease

To date, Hadassah has treated over 14 Russian children, saving their sight and hearing and offering them the opportunity to grow up and live normal lives.


Wednesday, Sep 28 2016

Hadassah Medical Organization Goes on High Alert for Peres Funeral

Thousands of visitors, including high profile dignitaries, are expected to arrive in Jerusalem for the funeral of past Prime Minister and President Shimon Peres, who will be laid to rest on Friday, September 30.


Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.


Contact Us

40 Wall Street

New York, NY 10005


More ›

Membership Questions


(800) 664-5646

Donation Questions


(800) 928-0685

Missions Department


(800) 237-1517

Show More